SCHEDULE: Rubric Capital Discloses 5.56% Stake in QuidelOrtho

Rubric Capital Management LP and David Rosen have reported a beneficial ownership of 5.56% in QuidelOrtho Corporation's common stock.

Summary

• Rubric Capital Management LP and David Rosen, as Reporting Persons, collectively beneficially own 3,777,157 shares of QuidelOrtho Corporation's common stock.
• This ownership represents 5.56% of the total outstanding common stock of QuidelOrtho Corporation.
• The percentage is calculated based on 67,931,540 shares of common stock outstanding as of October 29, 2025, as reported in QuidelOrtho's Form 10-Q.
• Rubric Capital Management LP, an investment adviser, and David Rosen, its Managing Member, share both voting and dispositive power over all 3,777,157 shares.
• Rubric Capital Master Fund LP, one of the Rubric Funds, has the right to receive dividends or proceeds from the sale of more than 5% of the Common Stock.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer, except for activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant institutional stake by Rubric Capital Management LP suggests investor confidence in QuidelOrtho Corporation, without indicating any immediate activist intentions to influence control.

Positives

• A significant stake (5.56%) by an institutional investor like Rubric Capital Management LP can signal confidence in QuidelOrtho Corporation's long-term prospects.
• The filing indicates the investment is for ordinary course of business, suggesting a passive investment rather than an immediate activist intent to disrupt operations, which can be viewed positively by existing management.

Negatives

• No specific negative information regarding QuidelOrtho Corporation's performance or outlook is contained within this beneficial ownership report.

Risks

• The filing itself does not detail specific risks related to QuidelOrtho Corporation's business operations or financial health. It is a disclosure of beneficial ownership.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance from QuidelOrtho Corporation or the Reporting Persons regarding the issuer's future performance.

Management Comments

• Rubric Capital Management LP and David Rosen certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

StockSavvy.ai notes that a significant stake by an investment adviser like Rubric Capital Management LP in a healthcare diagnostics company such as QuidelOrtho Corporation often reflects a belief in the company's long-term value proposition within the evolving healthcare sector. This type of institutional investment can be a vote of confidence in the company's market position and future growth potential, especially in a sector undergoing technological advancements and shifting demand patterns.

Comparison to Industry Standards

• This filing is a disclosure of beneficial ownership and does not contain performance metrics for direct comparison to industry standards or specific comparable companies. The 5.56% stake is a substantial position for an institutional investor, indicating a meaningful commitment to QuidelOrtho Corporation.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor holding a 5.56% stake may be viewed positively, potentially signaling validation of the company's value and attracting further institutional interest.
• Management: The certification that the investment is not for changing or influencing control (except for Rule 14a-11 nominations) suggests a generally supportive or passive stance from this large shareholder, which could provide stability.

Key Dates

Recommendation

The filing indicates a significant institutional investor has taken a substantial stake in QuidelOrtho, which can be a positive signal of confidence. However, as a Schedule 13G, it primarily reports ownership and does not provide new financial performance data or strategic updates from the company itself. While the institutional interest is noteworthy, it doesn't inherently warrant a 'buy' without further fundamental analysis of QuidelOrtho's operations and financials. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive signal while awaiting more comprehensive company-specific news.

Keywords

QuidelOrtho Corporation, Rubric Capital Management, David Rosen, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Healthcare Diagnostics, Medical Devices